BOLDER BIOTECHNOLOGY INC — Federal Contracts, Awards & Government Contractor Profile

About BOLDER BIOTECHNOLOGY INC

Bolder BioTechnology is a clinical-stage protein therapeutics company focused on developing longer-acting, more effective protein treatments for hematological, endocrine, cancer, and infectious disease indications. The company uses advanced protein engineering technologies to improve drug efficacy and reduce dosing frequency.

Advanced protein engineering and targeted bioconjugation technologiesDevelopment of long-acting, enhanced protein therapeuticsPipeline targeting hematological, endocrine, cancer, and infectious disease marketsSite-specific PEGylation and ImmunoFusion Protein technologies

Recent Federal Awards

Award	Agency	Amount	Date
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"	Department of Health and Human Services	$3.1M
Federal contract award	Department of Defense	$250K

Is this your company?

Claim BOLDER BIOTECHNOLOGY INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.

Claim BOLDER BIOTECHNOLOGY INC & see your matches

Free to claim. Takes about a minute.

Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.